Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: A meta-analysis

被引:77
|
作者
Albrecht, Julia [1 ]
Garbade, Sven F. [1 ]
Burgard, Peter [1 ]
机构
[1] Heidelberg Univ, Ctr Paediat & Adolescent Med, D-69120 Heidelberg, Germany
来源
关键词
Phenylketonuria; Phenylalanine; Meta-analysis; Neuropsychological speed test; Treatment recommendations; EARLY-TREATED PHENYLKETONURIA; EVENT-RELATED POTENTIALS; SUSTAINED ATTENTION; EXECUTIVE FUNCTION; TYROSINE SUPPLEMENTATION; PREFRONTAL DYSFUNCTION; PLASMA PHENYLALANINE; BRAIN-FUNCTION; ADULT PATIENTS; CHILDREN;
D O I
10.1016/j.neubiorev.2008.11.001
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Although pathogenesis of phenylketonuria is not completely understood, a low phenylalanine diet is effective to prevent severe neurological impairment, mental retardation and behavioural difficulties. Treatment recommendations heavily rely on neuropsychological research; however, single study results are ambiguous, what is reflected in substantial variation of US, British, German, Dutch and French recommendations for blood phenylalanine concentrations for adolescents and adults. We conducted a meta-analysis estimating the influence of age, phenylalanine level, and type of neuropsychological test on effect sizes (standardized differences between controls and patients) of computer-based speed measurements in phenylketonuric patients. The effect of blood phenylalanine level on effect size was more pronounced in children and adolescents than in adults, with choice reaction time being particularly sensitive for phenylalanine concentrations. Results corroborate all recommendations for children. With the exception of the US and Dutch recommendations, all recommendations for adolescents seem to be too liberal. The same effect size is predicted for adult phenylalanine concentrations between 750 and 1500 mu mol/L not suggesting a preference for any of the published treatment recommendations for adulthood. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:414 / 421
页数:8
相关论文
共 50 条
  • [1] Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta-analysis
    Waisbren, Susan E.
    Noel, Kay
    Fahrbach, Kyle
    Cella, Catherine
    Frame, Diana
    Dorenbaum, Alex
    Levy, Harvey
    [J]. MOLECULAR GENETICS AND METABOLISM, 2007, 92 (1-2) : 63 - 70
  • [2] Estimating the probability of IQ impairment from blood phenylalanine for phenylketonuria patients: a hierarchical meta-analysis
    Fonnesbeck, Christopher J.
    McPheeters, Melissa L.
    Krishnaswami, Shanthi
    Lindegren, Mary Louise
    Reimschisel, Tyler
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2013, 36 (05) : 757 - 766
  • [3] The role of phenylalanine levels in the neuropsychological and neuroanatomical status of adult patients with phenylketonuria: The impact of fluctuations
    Costa-Lathan, Christian
    Vazquez-Agra, Nestor
    Marques-Afonso, Ana-Teresa
    Cruces-Sande, Anton
    Martinez-Olmos, Miguel-Angel
    Araujo-Vilar, David
    Hermida-Ameijeiras, Alvaro
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (02) : 149 - 158
  • [4] TREATED PHENYLKETONURIA - INTELLIGENCE AND BLOOD PHENYLALANINE LEVELS
    FULLER, R
    SHUMAN, J
    [J]. AMERICAN JOURNAL OF MENTAL DEFICIENCY, 1971, 75 (05): : 539 - &
  • [5] Phenylalanine Tolerance over Time in Phenylketonuria: A Systematic Review and Meta-Analysis
    Pinto, Alex
    Ilgaz, Fatma
    Evans, Sharon
    van Dam, Esther
    Rocha, Julio Cesar
    Karabulut, Erdem
    Hickson, Mary
    Daly, Anne
    MacDonald, Anita
    [J]. NUTRIENTS, 2023, 15 (16)
  • [6] Performance of laboratory tests used to measure blood phenylalanine for the monitoring of patients with phenylketonuria
    Moat, Stuart J.
    Schulenburg-Brand, Danja
    Lemonde, Hugh
    Bonham, James R.
    Weykamp, Cas W.
    Mei, Joanne V.
    Shortland, Graham S.
    Carling, Rachel S.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2020, 43 (02) : 179 - 188
  • [7] Evaluating the Influence of Social Determinants of Health on Blood Phenylalanine Levels in Phenylketonuria Patients
    Afseth, Cassandra
    Knutsen, Josh
    Lamborn, Thomas
    Vucko, Erika
    Havens, Kirsten
    Shim, Soo
    Baker, Joshua
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2024,
  • [8] Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels
    Pardo, Jessica
    Capdevila-Lacasa, Clara
    Segura, Barbara
    Pane, Adriana
    Montserrat, Cristina
    Forga-Visa, Maria de Tallo
    Moreno, Pedro J.
    Garrabou, Gloria
    Grau-Junyent, Josep M.
    Junque, Carme
    [J]. JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2024, 16 (01)
  • [9] Stability of blood phenylalanine levels and IQ in children with phenylketonuria
    Anastasoaie, Vera
    Kurzius, Laura
    Forbes, Peter
    Waisbren, Susan
    [J]. MOLECULAR GENETICS AND METABOLISM, 2008, 95 (1-2) : 17 - 20
  • [10] A META-ANALYSIS OF GROWTH OUTCOMES IN PHENYLKETONURIA PATIENTS TREATED WITH A PHENYLALANINE-RESTRICTED DIET plus SAPROPTERIN
    Muntau, Ania
    Feillet, Francois
    Burton, Barbara
    MacDonald, Anita
    Wessel, Ann
    Alvarez, Ignacio
    Lilienstein, Joshua
    Lane, Paul
    Jurecki, Elaina
    Longo, Nicola
    [J]. MOLECULAR GENETICS AND METABOLISM, 2019, 127 (03) : 290 - 290